CBD isolate is a pure crystalline powder that is 99+% pure CBD. CBD isolate contains only CBD. All plant matter contained in hemp, including oils, waxes, chlorophyll and more, are removed. The result is chemically pure, odorless, and flavorless CBD powder.
All of our CBD isolate is sourced from hemp that is grown in compliance with the 2018 Federal Farm Bill. It is farmed without chemical fertilizers or pesticides. Every batch is third-party tested for cannabinoid potency, residual solvents, and presence of pesticides.
CBD Winterized Crude
55% to 65%
GVB is one of a handful of companies that sells CBD winterized crude. ”Crude” refers to the base product produced in the initial extraction of our hemp material. GVB’s crude typically ranges in CBD potency from 55% to 65%. During the extraction process, we maintain high levels of other cannabinoids including CBC, CBN, CBG, and CBD-V.
Once the extraction process is complete, the crude is sent to post-processing where it is winterized and the THC is removed. Winterization is a refining process in which raw extract is put through an alcohol wash that removes undesirable components of the crude extract. The raw extract is immersed in alcohol and then frozen—hence its name. This process separates the cannabinoids from other compounds like waxes, lipids, and chlorophyll.
85% to 90%
CBD distillate, one of GVB's core products, is the finished product achieved after the winterized crude is distilled. CBD Distillate is substantially purer than crude because the distillation process removes most of the remaining plant materials. The distillate is a viscous oil with a golden color and is prized by formulators for its ease of use. The distillation process retains all of the rich levels of minor cannabinoids (CBC, CBN, and CBG) that are present in the crude. Our distillate typically ranges in potency from 85% to 90% total cannabinoids.
GVB is highly regarded in the industry for producing one of the highest quality distillates available on the market today. All of our CBD distillate is sourced from hemp that is grown in compliance with the 2018 Federal Farm Bill. It is farmed without chemical fertilizers or pesticides. Every batch is third-party tested for cannabinoid potency, residual solvents, and presence of pesticides.
Crystal Resistant CBD Distillate
GVB Biopharma’s crystal resistant CBD distillate (CRD) is a unique broad-spectrum oil that contains an impressive array of cannabinoids, including CBD, CBG, CBN, CBC, and CBD-V. Our proprietary distillation process obviates the propensity for distillates to crystallize. The resulting distillate is ideal for the vape market. GVB is the market’s largest producer of this highly specialized product.
CRD is formulated for stability and has no added cutting agents. It can be introduced directly to a vape cartridge, allowing companies to formulate vape products that are 100% hemp extract-derived. If stored properly, this product will remain stable for up to three months without crystallizing.
Cutting-Edge Cannabinoids: CBG and Beyond
GVB Biopharma takes the long-term view that significant future growth in the hemp industry will come from a wide array of cannabinoids—not just CBD.
An example is these novel, cutting-edge cannabinoids is CBG. GVB is actively entering into the CBG arena, working closely with a leading Oregon genetics firm—Oregon CBD—to bring to market products derived from their latest strain of high-CBG hemp. GVB has secured large quantities of CBG hemp biomass and has begun large scale production of CBG isolate and CBG distillate. As a result, we have secured an industry-leading position in the production and distribution of these CBG products.
GVB is one of a select few manufacturers that offer 99% pure CBG isolate. GVB predicts rapid growth in CBG sales through late 2019 and into 2020.
GVB views CBG as particularly interesting because it is the precursor to all other cannabinoids. With CBG production already well underway, we plan to proceed toward production of CBN and CBC from CBG feedstock. We intend to commercially offer CBN and CBC in the fourth quarter of 2019.